Anti-Obesity Injection Attracts More Patients Than Pills: Chart

An injection that’s more popular than a pill? That’s the case for Novo Nordisk A/S’s Saxenda shot for obesity. While the injection may be less pleasant than taking a pill, it’s effective: Saxenda and Vivus Inc.’s Qsymia have the highest odds of achieving at least a 5 percent reduction in weight, according to data published in June.

Before it's here, it's on the Bloomberg Terminal.
LEARN MORE